Why Integer Holdings Stock Flew Higher on Friday This Week
Friday brought a notable rally for Integer Holdings as earnings beat and optimistic analyst updates boosted sentiment...
Yield Sp 500 Fund Vs Multi Asset Retirement Portfolio
This article compares yields from SP 500 funds and multi-asset retirement portfolios, detailing factors that influence income streams.
25,010 articles
There’s Vital Difference Medicare Investors Should Watch
A fresh study contrasts how traditional Medicare and Medicare Advantage manage stroke care, with potential implicatio...
WTRG Reports Earnings: What It Means for Investors
WTRG just released its quarterly earnings, and the market is parsing revenue growth, margins, and forward guidance. T...
General Mills Down 20%: Betting to Win Back Shoppers
General Mills is down 20% this year as executives double down on value promotions to win back budget-conscious shoppe...
Atlassian Stock Fell February: Why It Dropped 36% So Fast
February brought a sharp drop for Atlassian as investors digested earnings signals and AI risk. This guide breaks dow...
StubHub Stock Just Crashed: What Investors Should Do Next
A disappointing earnings quarter sent stubhub stock just crashed. This guide breaks down the reasons, what it signals...
Grocery Outlet Scholastic Face Fresh Analyst Scrutiny
Grocery Outlet faces supply-chain and affordability pressures, while Scholastic gauges upside; analysts adjust target...
Oracle Price Target $240 Sparks AI Cloud Rally Today
Analysts raise the oracle price target $240 after Oracle reports resilient AI cloud demand and stronger-than-expected...
Ulta Beauty Price Prediction Turns Bullish After Selloff
Ulta Beauty shares have tumbled in the wake of earnings, but analysts see a potential entry point. The ulta beauty pr...
Bitcoin Holds Above $74,000 as Banks Brace for Decisions
Bitcoin holds above $74,000 as policymakers prepare to announce rate decisions this week, setting the tone for crypto...
Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status